BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will expand its ...
This report on the Cell Characterization Assays Kits Market assures a treasure of information on a plethora of growth opportunities. The study includes expansive research by expert analysts. All the ...
Invitrogen Corporation announced the launch of the JAK2 [pYpY1007/1008] phosphoELISA™ kit, said to be the first complete ELISA assay to quantitatively detect phosphorylated JAK2. Phosphorylation, or ...
Invitrogen Corporation announced the launch of the company’s EXPRESS SYBR® GreenER™ qRT-PCR and EXPRESS SuperScript® qRT-PCR SuperMixes. Optimized for use in high-throughput fast cycling quantitative ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
BioPorto Exhibiting NGAL Biomarker at ASN Kidney Week – Antibodies, ELISA kits, and Clinical Chemistry Assays for Early Drug Development and Clinical Research COPENHAGEN, DENMARK and BOSTON, MA, USA, ...
Will enable cancer researchers to accelerate identification and optimization of therapeutic leads by better decoding KRAS mutations present in 25% of tumors WALTHAM, Mass. — PerkinElmer, Inc., a ...
Pharmas and biotechs struggle to screen large quantities of compounds, hoping to eliminate early those that would prove more destructive than beneficial. One avenue toward a successful resolution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback